US Broker Ratings

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 12% Upside Potential Amidst Healthcare Innovations

InnovAge Holding Corp. (NASDAQ: INNV) is catching the attention of investors with its unique approach to elder care, operating within the expansive healthcare sector. Headquartered in Denver, Colorado, InnovAge focuses..

Simulations Plus, Inc. (SLP) Stock Analysis: Navigating the Healthcare Software Space with a 7.5% Revenue Growth

Simulations Plus, Inc. (NASDAQ: SLP), a renowned player in the healthcare sector, is making waves in the health information services industry with its innovative software solutions for drug discovery and..

Neuropace, Inc. (NPCE) Stock Analysis: 43% Potential Upside with Strong Buy Ratings

Neuropace, Inc. (NASDAQ: NPCE) is capturing attention in the healthcare sector, particularly within the medical devices industry, due to its innovative approach in treating drug-resistant focal epilepsy. With a market..

Butterfly Network, Inc. (BFLY) Stock Report: Promising 34% Upside Potential in the Medical Devices Sector

Butterfly Network, Inc. (NYSE: BFLY), a pioneering company in the healthcare sector, is making waves in the medical devices industry with its innovative ultrasound imaging solutions. Headquartered in Burlington, Massachusetts,..

Cel-Sci Corporation (CVM) Stock Analysis: Unpacking the 738% Potential Upside

In the dynamic world of biotechnology, Cel-Sci Corporation (CVM) stands out with a remarkable potential upside of nearly 739%, according to current analyst ratings. This intriguing figure is largely attributed..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating a 27.74% Upside Potential in the Healthcare Sector

Phibro Animal Health Corporation (NASDAQ: PAHC), a key player in the healthcare sector, particularly in the niche of specialty and generic drug manufacturing, is capturing investor attention with a notable..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Unpacking a Potential 41% Upside in the Biotech Sector

Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the biotechnology sector with its pioneering approach to precision medicine. Headquartered in Cambridge, Massachusetts, Relay Therapeutics focuses on the discovery and..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Challenges in the Healthcare Staffing Sector

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a pivotal player in the healthcare staffing sector, providing essential talent management services across the United States. With a market capitalization of..

SIGA Technologies Inc. (SIGA) Stock Analysis: Evaluating the Prospects Amid a Challenging Landscape

For investors keeping an eye on the healthcare sector, SIGA Technologies Inc. (NASDAQ: SIGA) presents a compelling case for analysis. Known for its focus on the health security market, SIGA’s..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Robust Revenue Growth and Analyst Optimism Signal Potential Upside

Sonida Senior Living, Inc. (SNDA), a notable player in the healthcare sector specializing in medical care facilities, presents a compelling opportunity for investors with its impressive revenue growth and bullish..

Fulgent Genetics, Inc. (FLGT) Investor Outlook: Navigating a Complex Landscape in the Diagnostics Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT) presents a fascinating case for investors seeking exposure to the healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of $601.21..

Kura Oncology, Inc. (KURA) Stock Analysis: A Biotech Innovator with a 173% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA) is making waves in the biotechnology sector with its innovative approach to cancer treatment. Based in San Diego, California, this clinical-stage biopharmaceutical company is dedicated..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Potential Upside of Over 57% Ignites Investor Interest

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is making waves in the biotechnology sector, attracting attention with its promising pipeline and a substantial potential upside. With a market capitalization of $1.37 billion,..

GH Research PLC (GHRS): Investor Outlook on a Biotech Stock with a 49% Potential Upside

GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company headquartered in Dublin, Ireland, is capturing the attention of investors with its innovative approach to treating depression. Specializing in the healthcare..

uniQure N.V. (QURE) Stock Analysis: A Biotech Powerhouse with a 56% Upside Potential

uniQure N.V. (QURE), a prominent player in the biotechnology sector, is catching the attention of investors with its robust portfolio of gene therapy candidates and a promising potential upside. Based..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: A Look at Its 95.76% Potential Upside

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a cutting-edge biotechnology firm specializing in genome editing, offers intriguing possibilities for investors focused on the healthcare sector. With its headquarters in Cambridge, Massachusetts, Intellia..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: A 50% Upside Potential Amidst Robust Revenue Growth

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), an innovative player in the healthcare sector, is attracting investor attention with its promising growth prospects. Specializing in developing therapies for chronic endocrine and..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Navigating a Potential 7.54% Upside in the Biotech Arena

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands at the forefront of the biotechnology sector, focusing its efforts on developing innovative therapeutics for infectious diseases. Headquartered in Warminster, Pennsylvania, Arbutus is a..

Auna SA (AUNA) Stock Analysis: Exploring a Compelling 35.91% Potential Upside

Auna SA (AUNA), a prominent player in the healthcare sector with operations spanning Mexico, Peru, and Colombia, presents an intriguing proposition for investors seeking promising growth in medical care facilities...

Iovance Biotherapeutics (IOVA) Stock Analysis: Unpacking the 65.7% Revenue Growth Potential

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) stands at the forefront of the biotechnology sector, captivating investors with its promising advancements in cell therapy for cancer treatment. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds